Biogen Idec third quarter 2014 revenues increase 37% to $2.5 billion
Biogen Idec reported third quarter 2014 revenue of $2.5 billion, a 37% increase compared to the 2013 third quarter. GAAP net income attributable to Biogen Idec for the third quarter of 2014 was $857 million, an increase of 76% versus the same period in the prior year. October 22, 2014